Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03207646 · ClinicalTrials.gov registry record · NA
Smartphone GUIded MeDication AdherencE and Rehabilitation in Patients With Coronary Artery Disease
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 63
- Enrollment target
NCT03207646: Clinical Trial NA study, sponsored by Stanford University.
NCT03207646 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 63 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03207646, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
Study Summary
This study evaluates a smartphone-based cardiac rehabilitation program in adults with coronary artery disease. Half of patients will participate in a smartphone-based cardiac rehabilitation program while the other half will receive standard-of-care.
Interventions
- OTHER BrightHeart®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2017-07-19 |
| Est. Completion | 2018-08-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03207646
The ClinicalTrials.gov registry entry for NCT03207646 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BrightHeart® is the first listed.
NCT03207646 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03207646 about?
NCT03207646 is a clinical study titled "Smartphone GUIded MeDication AdherencE and Rehabilitation in Patients With Coronary Artery Disease". This study evaluates a smartphone-based cardiac rehabilitation program in adults with coronary artery disease. Half of patients will participate in a smartphone-based cardiac rehabilitation program while the other half will receive standard-of-care.
What is the current status of trial NCT03207646?
This trial is currently terminated. It is a NA study. The enrollment target is 63 participants. The study started on 2017-07-19. Estimated completion is 2018-08-17.
What interventions are being tested in trial NCT03207646?
The interventions under investigation include: BrightHeart® (OTHER).
Who is sponsoring clinical trial NCT03207646?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.